Psykologselskabet Mathilde Frandsen Kopp ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  15.9% 15.6% 11.6% 13.0% 19.8%  
Credit score (0-100)  12 11 20 17 6  
Credit rating  BB BB BB BB B  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Gross profit  462 475 289 856 509  
EBITDA  26.0 47.9 -7.0 24.4 65.2  
EBIT  23.4 32.4 -17.3 14.1 54.8  
Pre-tax profit (PTP)  22.8 31.5 -17.7 11.3 53.0  
Net earnings  17.5 26.0 -17.7 10.2 41.2  
Pre-tax profit without non-rec. items  22.8 31.5 -17.7 11.3 53.0  

 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Tangible assets total  15.5 103 93.0 82.7 72.3  
Shareholders equity total  39.1 65.1 47.4 57.6 98.8  
Interest-bearing liabilities  0.2 60.4 30.4 42.4 31.4  
Balance sheet total (assets)  176 233 179 338 160  

Net Debt  -99.6 -40.4 -7.5 -177 -26.9  
 
See the entire balance sheet

Volume 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  462 475 289 856 509  
Gross profit growth  41.9% 2.8% -39.2% 196.4% -40.5%  
Employees  1 1 1 1 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  176 233 179 338 160  
Balance sheet change%  236.2% 32.8% -23.5% 89.1% -52.7%  
Added value  26.0 47.9 -7.0 24.4 65.2  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -5 72 -21 -21 -21  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  1.0 2.0 -1.0 1.0 2.0  

Profitability 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  5.1% 6.8% -6.0% 1.6% 10.8%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  20.5% 15.8% -8.4% 5.4% 22.1%  
ROI %  75.4% 39.3% -17.0% 15.8% 47.4%  
ROE %  57.5% 49.8% -31.5% 19.5% 52.7%  

Solidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  22.3% 30.2% 27.2% 17.1% 61.9%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -383.4% -84.5% 107.7% -727.3% -41.3%  
Gearing %  0.4% 92.8% 64.2% 73.5% 31.8%  
Net interest  0 0 0 0 0  
Financing costs %  88.4% 2.9% 0.9% 7.7% 5.1%  

Liquidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  1.2 0.7 0.5 0.8 1.0  
Current Ratio  1.2 0.6 0.5 0.8 1.0  
Cash and cash equivalent  99.7 100.9 38.0 219.7 58.3  

Capital use efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  23.7 -62.9 -70.3 -49.8 -1.0  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  0 0 0 0 0  
Added value / employee  26 48 -7 24 65  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  26 48 -7 24 65  
EBIT / employee  23 32 -17 14 55  
Net earnings / employee  17 26 -18 10 41